Literature DB >> 22464057

hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.

Na Cha1, Xiao-Yan Li, Yu-Jie Zhao, En-Hua Wang, Guang-Ping Wu.   

Abstract

PATIENTS AND METHODS: Human telomerase reverse transcriptase (hTERT) gene amplification was detected in pleural effusions of patients with lung cancer (n = 69) and in patients with benign lung disease (n = 46) when using a quantitative polymerase chain reaction (qPCR) technique.
RESULTS: hTERT gene relative copy numbers were significantly higher in effusions from patients with malignant, adenocarcinoma and small-cell lung cancer than in effusions from patients with benign lung disease (P < .01). By using a threshold value of 1.39, hTERT gene amplification was significantly more frequent in malignant effusions compared with benign effusions and more likely to be positive for malignant effusions, compared with cytology (P < .01). The diagnostic performance of qPCR of hTERT gene amplification was significantly higher than that of cytology, in terms of sensitivity (91.3% vs. 56.5%), negative predictive value (87.8% vs. 60.5%), and accuracy (92.2% vs. 73.9%).
CONCLUSIONS: Detecting hTERT gene amplification by qPCR appears suitable for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions. hTERT gene amplification was more sensitive than cytology and may be useful for diagnosing pleural micrometastases.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464057     DOI: 10.1016/j.cllc.2012.01.007

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  5 in total

1.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer--a case-control study in a Chinese population.

Authors:  Ajay A Myneni; Shen-Chih Chang; Rungui Niu; Li Liu; Heather M Ochs-Balcom; Yanli Li; Chao Zhang; Baoxing Zhao; Jianping Shi; Xiaoyou Han; Jiawei Li; Jia Su; Lin Cai; Shunzhang Yu; Zuo-Feng Zhang; Lina Mu
Journal:  Lung Cancer       Date:  2013-02-19       Impact factor: 5.705

2.  TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls.

Authors:  Wei Nie; Yuansheng Zang; Jiquan Chen; Qingyu Xiu
Journal:  Tumour Biol       Date:  2014-02-18

3.  Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study.

Authors:  Ying Wang; Weiyu Jiang; Xiaogu Liu; Yongjun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Genetic polymorphisms of TERT and CLPTM1L, cooking oil fume exposure, and risk of lung cancer: a case-control study in a Chinese non-smoking female population.

Authors:  Zhihua Yin; Zhigang Cui; Yangwu Ren; Haibo Zhang; Ying Yan; Yuxia Zhao; Rui Ma; Qianqian Wang; Qincheng He; Baosen Zhou
Journal:  Med Oncol       Date:  2014-07-19       Impact factor: 3.064

5.  PIF1 Affects the Proliferation and Apoptosis of Cervical Cancer Cells by Influencing TERT.

Authors:  Jiancai Wang; Xiaoyan Zhu; Pian Ying; Yingping Zhu
Journal:  Cancer Manag Res       Date:  2020-08-25       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.